drugset / Trial / NCT04541303

Topical Tranexamic Acid Use on Granulating Wounds Following Mohs Micrographic Surgery

NCT04541303

Phase 0 Completed 124 enrolled University of Missouri-Columbia
RandomizedParallel-groupTriple-blindPrevention

Summary

Bleeding after Mohs micrographic surgery for skin cancer is a low risk complication that can occur. This study aims to determine the effect of a drug, often used to reduce bleeding, called tranexamic acid when applied topically to the skin wound after surgery.

Timeline

Start
2020-10-08
Primary completion
2021-12-30
Completion
2021-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 25 mg/ml Topical

Indications

No indication recorded.